Makower is the Yock family professor of medicine and bioengineering at the Stanford Schools of Medicine and Engineering, and the Byers family director and co-founder of the Stanford Mussallem Center ...
Certain breakthrough-designated medical devices that receive market authorization will become eligible for Medicare coverage at the same time under a new coverage pathway announced Thursday by the FDA ...
Breakthrough medical devices will get faster insurance coverage in the US under a new government program that coordinates coverage with the approval process, streamlining one of the biggest hurdles ...
A new experimental drug for pancreatic cancer, daraxonrasib, appears to have extended the lives of some patients with advanced disease by several months, according to clinical trial results out last ...
The Trump administration unveiled a new program to speed up Medicare coverage for breakthrough devices, touting that the new pathway cuts red tape for medical device companies to gain reimbursement.
Medical nanobots are becoming an important topic in future medical technology because researchers believe they could improve diagnosis, treatment, and patient care. In healthcare technology, ...
The first phase of the European Medicines Agency (EMA) pilot programme providing expert panel advice for developers of breakthrough medical devices is now open and accepting applications until 22 May ...
BROOKLYN PARK, Minn., March 4, 2026 /PRNewswire/ -- Airiver Medical, a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions, was granted ...
The European Medicines Agency (EMA) has launched a pilot program to fast track breakthrough medical devices in the EU and get lifesaving technologies to patients sooner. The program will allow for ...
The European Medicines Agency (“EMA”) is set to launch a pilot programme providing expert panel advice for developers of breakthrough medical devices and in vitro diagnostic medical devices (“IVDs”) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results